Home › Funds › Two Sigma Investments › GLTO
Two Sigma Investments position in GLTO
DAMORA THERAPEUTICS INC
Latest position (Q2 2026)9.12K sh
Reported value held$237.16K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 152.35K | $547.00K | New |
| Q4 2021 | 256.82K | $778.00K | Add |
| Q1 2022 | 143.67K | $316.00K | Reduce |
| Q2 2022 | 63.30K | $110.00K | Reduce |
| Q3 2022 | 46.54K | $88.00K | Reduce |
| Q4 2022 | 17.43K | $20.05K | Reduce |
| Q1 2023 | 14.53K | $28.92K | Reduce |
| Q2 2023 | 12.73K | $32.08K | Reduce |
| Q3 2025 | 20.30K | $75.50K | New |
| Q2 2026 | 9.12K | $237.16K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding GLTO
- Fidelity Management & Research (FMR) 9.23M sh · $240.15M · Q2 2026
- BlackRock Inc 3.16M sh · $82.25M · Q2 2026
- Viking Global Investors 2.31M sh · $60.11M · Q2 2026
- JPMorgan Chase & Co 2.06M sh · $49.85M · Q2 2026
- Balyasny Asset Management 1.23M sh · $31.97M · Q2 2026
- Wellington Management Group 1.06M sh · $27.52M · Q2 2026
- Geode Capital Management 965.36K sh · $25.11M · Q2 2026
- BNY Mellon 151.02K sh · $3.93M · Q2 2026
- Charles Schwab Investment Management 142.14K sh · $3.70M · Q2 2026
- Morgan Stanley 119.03K sh · $3.10M · Q2 2026
- Wells Fargo & Co 47.46K sh · $1.23M · Q2 2026
- Citigroup Inc 43.42K sh · $1.13M · Q2 2026